ResMed Aktie
239,70
EUR
+5,30
EUR
+2,26
%
281,78
USD
+3,16
USD
+1,13
%
Werbung
ResMed Aktie Analyse
25.09.17 | ResMed Underweight | Barclays Capital | |
07.04.16 | ResMed Underweight | Barclays Capital | |
27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung